The territory will give infants Nirsevimab, a single-dose antibody injection with the brand name Beyfortus, that was authorized by Health Canada in April 2023. The antibody injection is approved for ...
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and ...
SNY's reasonable valuation, rising estimates, improving top line and positive pipeline progress are good enough reasons to ...